Skip to main content

Risk Assessment in Quality Management Systems

$349.00
Toolkit Included:
Includes a practical, ready-to-use toolkit containing implementation templates, worksheets, checklists, and decision-support materials used to accelerate real-world application and reduce setup time.
How you learn:
Self-paced • Lifetime updates
When you get access:
Course access is prepared after purchase and delivered via email
Your guarantee:
30-day money-back guarantee — no questions asked
Who trusts this:
Trusted by professionals in 160+ countries
Adding to cart… The item has been added

This curriculum spans the full risk management lifecycle in regulated medical device environments, comparable to a multi-phase advisory engagement that integrates risk processes into design, manufacturing, and post-market quality systems.

Module 1: Defining Risk Context within Regulatory Frameworks

  • Selecting applicable regulatory standards (e.g., ISO 13485, 21 CFR Part 820) based on product type and target markets.
  • Determining organizational boundaries for risk assessment scope when operating across multiple jurisdictions.
  • Aligning internal risk criteria with external mandates such as EU MDR or FDA expectations for post-market surveillance.
  • Documenting risk acceptance thresholds in alignment with legal liability exposure and insurance coverage limits.
  • Establishing roles for regulatory affairs in validating risk documentation for audit readiness.
  • Integrating product lifecycle stages into the risk context to ensure coverage from design to decommissioning.
  • Mapping stakeholder expectations (e.g., notified bodies, internal legal) into risk evaluation criteria.
  • Deciding whether to adopt a harmonized risk management file or maintain product-specific risk dossiers.

Module 2: Stakeholder Identification and Influence Mapping

  • Identifying all internal stakeholders (e.g., R&D, manufacturing, regulatory, legal) with risk decision authority.
  • Mapping external stakeholder influence (e.g., suppliers, distributors, healthcare providers) on risk outcomes.
  • Assigning escalation paths for unresolved risk conflicts between departments.
  • Documenting stakeholder risk tolerance through structured interviews or workshops.
  • Creating communication protocols for high-impact risk decisions involving clinical or safety implications.
  • Using influence/impact grids to prioritize stakeholder engagement in risk reviews.
  • Establishing formal sign-off requirements for risk acceptance by designated stakeholders.
  • Updating stakeholder maps when organizational restructuring affects risk ownership.

Module 3: Risk Identification Using Structured Techniques

  • Conducting failure mode and effects analysis (FMEA) for design and process risks in medical device development.
  • Applying hazard operability studies (HAZOP) to manufacturing processes involving sterile products.
  • Using fault tree analysis (FTA) to trace root causes of recurring nonconformances.
  • Facilitating cross-functional risk brainstorming sessions with documented traceability to inputs.
  • Extracting risks from complaint databases and field safety corrective actions (FSCAs).
  • Integrating supplier quality data into risk identification for outsourced processes.
  • Identifying emerging risks from changes in raw material sourcing or contract manufacturing.
  • Linking risk identification outputs to change control records for traceability.

Module 4: Risk Analysis: Severity, Likelihood, and Detection Scoring

  • Defining severity levels based on patient harm potential using ISO 14971 harm classification.
  • Calibrating likelihood scales using historical field failure rates and process capability data.
  • Adjusting detection scores based on the effectiveness of existing monitoring and inspection controls.
  • Resolving scoring disagreements through facilitated consensus sessions with clinical and engineering experts.
  • Documenting rationale for high-risk scores to support regulatory submissions.
  • Updating risk scores when new clinical evidence becomes available from post-market studies.
  • Applying weighting factors to risk components when regulatory requirements demand specific emphasis.
  • Maintaining version control for risk matrices when organizational risk criteria are revised.

Module 5: Risk Evaluation and Prioritization

  • Applying risk priority number (RPN) thresholds to determine which risks require immediate mitigation.
  • Using risk ranking and filtering to prioritize risks across a product portfolio with limited resources.
  • Conducting cost-benefit analysis for risk mitigation options against potential harm reduction.
  • Escalating high-severity, low-likelihood risks to executive leadership for strategic decision-making.
  • Deferring low-priority risks with documented justification and scheduled re-evaluation dates.
  • Aligning risk treatment plans with product development timelines and release gates.
  • Integrating risk evaluation outcomes into management review agendas.
  • Updating risk registers following internal audit findings or regulatory inspection observations.

Module 6: Risk Control Implementation and Verification

  • Designing engineering controls (e.g., fail-safes, interlocks) to mitigate device malfunction risks.
  • Implementing procedural controls such as work instructions and training to reduce human error.
  • Verifying control effectiveness through design verification testing and process validation.
  • Documenting control implementation in design history files and device master records.
  • Conducting usability testing to validate user-related risk controls in device interfaces.
  • Updating control strategies when process changes introduce new failure modes.
  • Coordinating with suppliers to implement and verify controls in outsourced manufacturing steps.
  • Linking risk controls to corrective and preventive action (CAPA) records for audit traceability.

Module 7: Residual Risk Assessment and Acceptance

  • Reassessing risk scores after control implementation to determine residual risk levels.
  • Obtaining formal sign-off from designated authorities on residual risk acceptance.
  • Documenting rationale for accepting residual risks that exceed predefined thresholds.
  • Communicating residual risks to users through labeling, instructions for use, and training.
  • Updating risk management files to reflect current residual risk status for regulatory submissions.
  • Reviewing residual risks during management reviews and product lifecycle milestones.
  • Re-evaluating residual risks when post-market data indicates higher-than-expected incident rates.
  • Archiving residual risk documentation for legacy products no longer in production.

Module 8: Risk Communication and Documentation

  • Developing standardized risk reporting templates for use in regulatory submissions.
  • Ensuring risk documentation is accessible to auditors and notified bodies during inspections.
  • Translating technical risk assessments into executive summaries for senior management.
  • Updating risk files in response to audit findings or nonconformance reports.
  • Integrating risk data into product labeling and safety updates for healthcare professionals.
  • Maintaining version-controlled risk management files across distributed teams.
  • Linking risk records to change control, CAPA, and complaint systems for end-to-end traceability.
  • Archiving risk documentation to meet statutory retention periods for medical devices.

Module 9: Monitoring, Review, and Continuous Improvement

  • Scheduling periodic risk review cycles aligned with product lifecycle phases.
  • Triggering ad hoc risk reviews following significant events such as recalls or adverse events.
  • Integrating post-market surveillance data into ongoing risk assessments.
  • Using key risk indicators (KRIs) to monitor trends in complaint volumes or process deviations.
  • Updating risk assessments when new standards or regulations are published.
  • Conducting retrospective benefit-risk analyses for products with long-term clinical use.
  • Aligning risk review outcomes with internal audit findings and management review inputs.
  • Implementing lessons learned from risk events into future product designs and processes.

Module 10: Integration of Risk Management into Quality System Processes

  • Embedding risk assessment requirements into design and development planning documents.
  • Linking risk inputs to supplier qualification and incoming inspection protocols.
  • Using risk-based thinking to determine sampling plans for process monitoring.
  • Incorporating risk considerations into internal audit planning and scope definition.
  • Aligning CAPA investigations with risk severity to prioritize resource allocation.
  • Applying risk-based approaches to calibration and maintenance scheduling of critical equipment.
  • Integrating risk data into management review metrics and performance dashboards.
  • Training quality system process owners on applying risk principles in daily operations.